QQQ   431.84 (+0.18%)
AAPL   169.76 (-1.70%)
MSFT   416.30 (+0.64%)
META   503.30 (+0.61%)
GOOGL   154.79 (-0.05%)
AMZN   184.08 (+0.25%)
TSLA   157.09 (-2.72%)
NVDA   871.25 (+1.31%)
AMD   163.25 (+1.83%)
NIO   3.81 (-2.06%)
BABA   69.79 (-1.18%)
T   16.07 (-1.05%)
F   12.17 (-0.49%)
MU   121.21 (-0.13%)
GE   155.45 (+1.14%)
CGC   6.96 (-0.29%)
DIS   114.27 (+1.17%)
AMC   2.74 (+10.93%)
PFE   25.86 (-0.19%)
PYPL   64.03 (+0.82%)
XOM   118.84 (-0.70%)
QQQ   431.84 (+0.18%)
AAPL   169.76 (-1.70%)
MSFT   416.30 (+0.64%)
META   503.30 (+0.61%)
GOOGL   154.79 (-0.05%)
AMZN   184.08 (+0.25%)
TSLA   157.09 (-2.72%)
NVDA   871.25 (+1.31%)
AMD   163.25 (+1.83%)
NIO   3.81 (-2.06%)
BABA   69.79 (-1.18%)
T   16.07 (-1.05%)
F   12.17 (-0.49%)
MU   121.21 (-0.13%)
GE   155.45 (+1.14%)
CGC   6.96 (-0.29%)
DIS   114.27 (+1.17%)
AMC   2.74 (+10.93%)
PFE   25.86 (-0.19%)
PYPL   64.03 (+0.82%)
XOM   118.84 (-0.70%)
QQQ   431.84 (+0.18%)
AAPL   169.76 (-1.70%)
MSFT   416.30 (+0.64%)
META   503.30 (+0.61%)
GOOGL   154.79 (-0.05%)
AMZN   184.08 (+0.25%)
TSLA   157.09 (-2.72%)
NVDA   871.25 (+1.31%)
AMD   163.25 (+1.83%)
NIO   3.81 (-2.06%)
BABA   69.79 (-1.18%)
T   16.07 (-1.05%)
F   12.17 (-0.49%)
MU   121.21 (-0.13%)
GE   155.45 (+1.14%)
CGC   6.96 (-0.29%)
DIS   114.27 (+1.17%)
AMC   2.74 (+10.93%)
PFE   25.86 (-0.19%)
PYPL   64.03 (+0.82%)
XOM   118.84 (-0.70%)
QQQ   431.84 (+0.18%)
AAPL   169.76 (-1.70%)
MSFT   416.30 (+0.64%)
META   503.30 (+0.61%)
GOOGL   154.79 (-0.05%)
AMZN   184.08 (+0.25%)
TSLA   157.09 (-2.72%)
NVDA   871.25 (+1.31%)
AMD   163.25 (+1.83%)
NIO   3.81 (-2.06%)
BABA   69.79 (-1.18%)
T   16.07 (-1.05%)
F   12.17 (-0.49%)
MU   121.21 (-0.13%)
GE   155.45 (+1.14%)
CGC   6.96 (-0.29%)
DIS   114.27 (+1.17%)
AMC   2.74 (+10.93%)
PFE   25.86 (-0.19%)
PYPL   64.03 (+0.82%)
XOM   118.84 (-0.70%)
LON:4BB

4basebio (4BB) Share Price, News & Analysis

GBX 1,070
+20.00 (+1.90%)
(As of 04:35 PM ET)
Today's Range
1,055
1,070
50-Day Range
700
1,050
52-Week Range
492
1,070
Volume
1,373 shs
Average Volume
3,254 shs
Market Capitalization
£137.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About 4basebio

4basebio PLC engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally. It provides AVV and Lentivirus manufacturing services for use in gene therapies and vaccines. The company offers access to its targeted non-viral delivery platform, Hermes. It serves biotech, pharma, and contract development and manufacturing organization. The company was formerly known as 4basebio UK Societas and changed its name to 4basebio PLC in July 2021. 4basebio PLC was founded in 2008 and is based in Cambridge, the United Kingdom.

4BB Stock Price History

4BB Stock News Headlines

AI “wealth window” is closing soon!
Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.
4basebio Plc - Exercise of Options and Issue of Equity
4basebio Plc - Half-year Report
4basebio Plc - Research Collaboration
4basebio Plc - Result of AGM
4basebio Plc - Director/PDMR Shareholding
AI “wealth window” is closing soon!
Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.
4BASEBIO UK SOCIETAS (4BB)
See More Headlines
Receive 4BB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 4basebio and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
78
Year Founded
N/A

Profitability

Net Income
£-6,280,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£311,000.00
Cash Flow
GBX 66.55 per share
Book Value
GBX 28 per share

Miscellaneous

Free Float
N/A
Market Cap
£137.07 million
Optionable
Not Optionable
Beta
1.10
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Dr. Heikki Lanckriet Ph.D. (Age 47)
    CEO, Chief Scientific Officer & Executive Director
    Comp: $448.9k
  • Mr. David Roth (Age 57)
    CFO, Company Secretary & Executive Director
    Comp: $323.1k
  • Mr. Mark Cooper
    Head of Manufacturing

4BB Stock Analysis - Frequently Asked Questions

How have 4BB shares performed in 2024?

4basebio's stock was trading at GBX 680 at the beginning of the year. Since then, 4BB shares have increased by 55.1% and is now trading at GBX 1,055.
View the best growth stocks for 2024 here
.

How do I buy shares of 4basebio?

Shares of 4BB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:4BB) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners